Skip to content

Evaluating dexmedetomidine and clonidine as enhancers of spinal anesthesia in patients undergoing lower abdominal surgery

A prospective randomized double blind study to compare effect of subcutaneous dexmedetomidine versus clonidine as an adjuvant to spinal anaesthesia in patients undergoing lower abdominal surgeries - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077858
Enrollment
60
Registered
2024-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: Group D - 30 patients will be given 0.5 microgram per kilogram of dexmedetomidine diluted up to 1 milliliter with normal saline subcutaneously given with using 26 gauge

Sponsors

JLN medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Age group between 20 and 70 years -Body weight 40 to 80 kg. - Patients belonging to ASA (American Society of anaesthesiologist) class-I and II. - Patients undergoing various infraumbilical surgeries

Exclusion criteria

Exclusion criteria: -Patient’s refusal and uncooperative patients. -Any known hypersensitivity or contraindication to bupivacaine , clonidine and Dexmedetomidine., - Local pathology at the site of injection or disability limiting the performance of spinal block. - History of convulsion, altered coagulation profile, bleeding disorder, pre-existing neurological deficit, surgeries in prone position , obstructive sleep apnea, thyroid disorder, known allergy to bupivacaine, dexmedetomidine, clonidine. -Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above). -Patients having a history of significant neurological, psychiatric, or neuromuscular disorders.

Design outcomes

Primary

MeasureTime frame
duration of analgesiaTimepoint: Baseline to 60 minutes

Secondary

MeasureTime frame
-Onset and duration of sensory block. - Onset and duration of motor block. - The intraoperative hemodynamic variability ( haemodynamic parameters) - Postoperative Visual analog scale (VAS) score - Ramsay sedation scale - Total analgesia requirement in 24 hour -Adverse effects if anyTimepoint: 24 hours

Countries

India

Contacts

Public ContactDr Veena Patodi

JLN medical college and hospital, Ajmer

veenapatodi@gmail.com9414008276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026